- JP-listed companies
- K Pharma,Inc.
K Pharma,Inc.JP:4896
Market cap
¥8.6B
P/E ratio
Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | |
Net sales | - | - | 1,000 |
Cost of sales | - | - | 90 |
Gross profit (loss) | - | - | 910 |
Selling, general and administrative expenses | 219 | 354 | 544 |
Operating profit (loss) | -219 | -354 | 366 |
Interest income | 0 | 0 | 0 |
Commission income | - | 0 | 0 |
Non-operating income | 0 | 0 | 0 |
Share issuance costs | 1 | 5 | 12 |
Going public expenses | - | - | 10 |
Other | 0 | 0 | 0 |
Non-operating expenses | 1 | 6 | 22 |
Ordinary profit (loss) | -221 | -359 | 344 |
Impairment losses | 8 | 31 | 43 |
Extraordinary losses | 8 | 31 | 43 |
Profit (loss) before income taxes | -229 | -391 | 301 |
Income taxes - current | 1 | 2 | 41 |
Income taxes | -0 | 2 | 41 |
Profit (loss) | -229 | -392 | 260 |